Clinical Trial Update: Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of GTX (gemcitabine/taxotere/xeloda) with cisplatin in metastatic pancreatic cancer completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GTX (gemcitabine/taxotere/xeloda) with cisplatin

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-01-23